Jul 25, 2024 | Defective Drugs, Defective Product, Medical News, Personal Injury, Product Liability
In recent years, Tepezza, a groundbreaking treatment for Thyroid Eye Disease (TED), has offered hope to many patients suffering from this debilitating condition. However, as its usage has increased, so too have reports of severe side effects, particularly those...
Jul 23, 2024 | Defective Drugs, Personal Injury, Product Liability
Ozempic, a medication produced by Novo Nordisk, has garnered significant attention not just for its effectiveness in treating type 2 diabetes, but also due to a spate of consumer lawsuits. The medication, which contains the active ingredient semaglutide, has become...
Jul 17, 2024 | Chemical Injury, Defective Product, Formaldehyde Exposure, Personal Injury, Product Liability
Formaldehyde is a chemical compound widely used in various industries, including manufacturing, textiles, and cosmetics. Despite its ubiquitous presence, formaldehyde has been classified as a human carcinogen by the International Agency for Research on Cancer (IARC)...
Jul 8, 2024 | Defective Drugs, Ozempic Injury, Ozempic Lawsuit, Ozempic Lawsuits, Product Liability
A recent study suggests that individuals using Ozempic or Wegovy may face a higher risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare form of eye stroke causing sudden vision loss. Despite this, doctors advise that these medications...
Jul 3, 2024 | Children's Product Liability, Defective Children's Product, Defective Toys, Product Liability, Product Recall
The Consumer Product Safety Commission (CPSC) and REI are recalling more than 75,000 children’s bicycles due to a defect with the training wheel assembly. With at least four reports of injuries so far, parents should be aware of the risk if they own one of the...
Jul 1, 2024 | Mass Tort News, Multidistrict Litigation, Personal Injury, Product Liability
At Kherkher Garcia, our national mass tort attorneys consistently monitor and track developments in various mass tort cases, including class action MDLs pending in federal courts. We observe the volume of new cases filed or transferred into each MDL, identify trends...